Reporte zur Charge ENO117

Symptomtext

Chronic hives; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 (Lot number: ENO117) at the age of 64 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic obstructive pulmonary disease" (unspecified if ongoing). Concomitant medication(s) included: SPIRIVA. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955), administration date: 04Mar2021, for COVID-19 Immunization. The patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The following information was reported: URTICARIA (medically significant) with onset 08Apr2021, outcome "not recovered", described as "Chronic hives". The event "chronic hives" was evaluated at the physician office visit. Therapeutic measures were taken as a result of urticaria and include antihistamines and cream.